Dr. Amir Bajoghli Published Findings on Hydroxychloroquine-induced Hyperpigmentation

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MCLEAN, VA / ACCESSWIRE / November 19, 2020 / Dr. Amir Bajoghli of Skin and Laser Dermatology Center and Clinical Assistant Professor of Dermatology at Georgetown University School of Medicine and Dr. Michael A. Cardis of MedStar Georgetown University Hospital, along with medical assistant Gabriela Hernandez, recently published their findings on hydroxychloroquine-induced hyperpigmentation in the premier and esteemed Journal of Rheumatology.

Their findings highlight hyperpigmentation of the skin as an underrecognized side-effect of hydroxychloroquine (HCQ). Dr. Amir Bajoghli encountered a patient who had been taking HCQ for twelve years to treat an autoimmune disease called systemic lupus erythematosus (SLE). HCQ is a common treatment for SLE, however, the darkening skin on her upper arms is not regularly diagnosed as a side-effect. This is important for the education of prescribing physicians.

Dr. Amir Bajoghli is honored to publish this finding with his colleague Dr. Cardis, a board-certified dermatologist and dermatopathologist who determined the pathology and contributed to the reporting of this publication.

Dr. Bajoghli has been active in the field of dermatology, Mohs micrographic surgery, and cosmetic services for over twenty years. He regularly presents lectures to other physicians regionally and internationally, and teaches medical students and dermatology residents at Georgetown University School of Medicine.

Dr. Bajoghli of Skin & Laser Dermatology Center can be reached at his Virginia offices:

McLean:
1359 Beverly Rd., 2nd Floor
McLean, VA 22101
P: (703) 893-1114

Woodbridge:
2200 Opitz Blvd., Suite 100
Woodbridge, VA 22191
P: (703) 492-4140

SOURCE: Skin and Laser Dermatology Center

View source version on accesswire.com:
https://www.accesswire.com/617449/Dr-Amir-Bajoghli-Published-Findings-on-Hydroxychloroquine-induced-Hyperpigmentation

Staff

Recent Posts

Novel Artificial Intelligence Models Detect Type 1 Diabetes Risk Before Clinical Onset

New Studies Highlight Machine Learning as Potential Early Risk Detection Strategy CHICAGO, June 20, 2025…

9 hours ago

Artificial Intelligence (A.I.) in Life Science: New Survey of 408 Researchers Reveals Split Sentiment, Surging Adoption, and Rising Trust Barriers

ARLINGTON, Va., June 20, 2025 /PRNewswire/ -- New survey data from 408 global scientists and researchers…

15 hours ago

Salem Dentist (Smiles Of Salem) Stands with Veterans in National Push for Better Healthcare Protections

This Fourth of July, Dr. Harbpinder Shevchenko, DMD of Smiles of Salem is going beyond…

15 hours ago

American Textile Company’s Centennial Gala Marks 100 Years of Success!

Pittsburgh Event Celebrates Employees, Partners and a Commitment to Growth DUQUESNE, Pa., June 20, 2025…

15 hours ago

Nihar Gala Launches CareIQ, a Pioneering Remote Patient Monitoring Company, and Releases Inspiring New Book “The Strength to Endure”

SEAFORD, Del., June 20, 2025 /PRNewswire/ -- Acclaimed physician, entrepreneur, and visionary healthcare leader Nihar Gala…

15 hours ago